Free Trial
ASX:NAN

Nanosonics (NAN) Stock Price, News & Analysis

Nanosonics logo

About Nanosonics Stock (ASX:NAN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
740,249 shs
Average Volume
N/A
Market Capitalization
$1.02 billion
P/E Ratio
78.25
Dividend Yield
8.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories, as well as research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; Nanosonics AuditPro, an infection control workflow compliance management; Trophon EPR for mitigating the risk of exposure to toxic chemicals; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Receive NAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanosonics and its competitors with MarketBeat's FREE daily newsletter.

NAN Stock News Headlines

Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
ASX Stocks That Could Be Undervalued In April 2025
Wilsons Keeps Their Buy Rating on Nanosonics Limited (NNCSF)
See More Headlines

NAN Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Nanosonics investors own include Nanosonics (NNCSF), Calix (CXL), Insignia Financial (IFL), Bubs Australia (BUB), EML Payments (EML), Isracann Biosciences (ISCNF) and Audentes Therapeutics (BOLD).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
Financial Services
Current Symbol
ASX:NAN
CIK
N/A
Fax
N/A
Employees
482
Year Founded
N/A

Profitability

Trailing P/E Ratio
78.25
Forward P/E Ratio
N/A
P/E Growth
2.74
Net Income
$12.97 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$170.01 million
Price / Cash Flow
25.90
Book Value
A$0.60 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.02 billion
Optionable
Not Optionable
Beta
1.55
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (ASX:NAN) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners